CORTICOTROPIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Corticotropin, and what generic alternatives are available?
Corticotropin is a drug marketed by Organics Lagrange and Watson Labs and is included in two NDAs.
The generic ingredient in CORTICOTROPIN is corticotropin. There are ten drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the corticotropin profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CORTICOTROPIN?
- What are the global sales for CORTICOTROPIN?
- What is Average Wholesale Price for CORTICOTROPIN?
Summary for CORTICOTROPIN
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 19 |
Clinical Trials: | 57 |
Patent Applications: | 2,492 |
DailyMed Link: | CORTICOTROPIN at DailyMed |
Recent Clinical Trials for CORTICOTROPIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yangzhou University | N/A |
Rutgers, The State University of New Jersey | Phase 2 |
Feinstein Institute for Medical Research | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for CORTICOTROPIN
US Patents and Regulatory Information for CORTICOTROPIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organics Lagrange | CORTICOTROPIN | corticotropin | INJECTABLE;INJECTION | 010831-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Organics Lagrange | CORTICOTROPIN | corticotropin | INJECTABLE;INJECTION | 010831-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | CORTICOTROPIN | corticotropin | INJECTABLE;INJECTION | 088772-001 | Nov 21, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |